跳至主要内容
临床试验/JPRN-UMIN000038084
JPRN-UMIN000038084已完成未知

The safety SUrvey of pneumonitis induced by the combination of platinum, pemetrexed and pembrolizumab in chemo-naive non-small cell lung cancer patient in the real-world setting. - SUSPECT study

Kobe city medical center general hospital0 个研究点目标入组 299 人开始时间: 2019年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
299

研究概览

简要总结

Radiographic features at diagnosis predominantly comprised an organizing pneumonia pattern. Twelve patients experienced a worsening respiratory status during pneumonitis management, which was associated with a high mortality rate during treatment. Severe grade at pneumonitis diagnosis, diffuse alveolar damage (DAD) pattern, and disease extent in the lungs were significantly associated with worsening respiratory status.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 120years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验